- Home
- ZGM vs QTTB Comparison
ZGM vs QTTB Comparison
Compare ZGM & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGM
- QTTB
- Stock Information
- Founded
- ZGM 2019
- QTTB 2015
- Country
- ZGM Macau
- QTTB United States
- Employees
- ZGM N/A
- QTTB N/A
- Industry
- ZGM Professional Services
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- ZGM Consumer Discretionary
- QTTB Health Care
- Exchange
- ZGM Nasdaq
- QTTB Nasdaq
- Market Cap
- ZGM 32.6M
- QTTB 26.3M
- IPO Year
- ZGM 2025
- QTTB N/A
- Fundamental
- Price
- ZGM $2.10
- QTTB $2.10
- Analyst Decision
- ZGM
- QTTB Hold
- Analyst Count
- ZGM 0
- QTTB 7
- Target Price
- ZGM N/A
- QTTB $12.17
- AVG Volume (30 Days)
- ZGM 64.6K
- QTTB 84.9K
- Earning Date
- ZGM 01-06-2026
- QTTB 11-13-2025
- Dividend Yield
- ZGM N/A
- QTTB N/A
- EPS Growth
- ZGM 401.52
- QTTB N/A
- EPS
- ZGM 0.17
- QTTB N/A
- Revenue
- ZGM $3,620,780.00
- QTTB N/A
- Revenue This Year
- ZGM N/A
- QTTB N/A
- Revenue Next Year
- ZGM N/A
- QTTB N/A
- P/E Ratio
- ZGM $12.36
- QTTB N/A
- Revenue Growth
- ZGM 211.78
- QTTB N/A
- 52 Week Low
- ZGM $1.90
- QTTB $1.35
- 52 Week High
- ZGM $4.51
- QTTB $32.63
- Technical
- Relative Strength Index (RSI)
- ZGM N/A
- QTTB 37.62
- Support Level
- ZGM N/A
- QTTB $2.11
- Resistance Level
- ZGM N/A
- QTTB $2.42
- Average True Range (ATR)
- ZGM 0.00
- QTTB 0.23
- MACD
- ZGM 0.00
- QTTB -0.05
- Stochastic Oscillator
- ZGM 0.00
- QTTB 7.14
About ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.
About QTTB Q32 Bio Inc. Common Stock
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.